ERBB2 and breast carcinoma: Breast cancer treatment is dependent on disease staging, menopausal status, and receptor type in BC cells (oestrogen‐positive cells, human epidermal growth factor receptor 2 [HER2]‐positive cells, or progesterone‐positive cells).